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We used a polyclonal antiserum directed against calpain II to study the distribution of that enzyme in rat sciatic nerve. Western blot of 
nerve homogenate showed that the antibody reacted with a single protein band of 80 kDa, corresponding to the catalytic subunit of calpain 
II. By light microscopy, immunoreactivity appeared predominantly in Schwann cell cytoplasm. By electron microscopy, ealpain II was es- 
pecially dense along the plasmalemma of Sehwann cells, and was also seen in axoplasm. 
Calpains (calcium activated neutral  protease,  EC 
3.4.22.17) are a widely distributed family of  cysteine pro- 
teases 9. Calpain I is activated by/~M Ca 2+, while calpain 
II  requires mM Ca 2+ for activation 17'1s'3°. Along with 
their endogenous inhibitor calpastatin 19, both enzymes 
are found in most tissues including the nervous system 6' 
32. Each calpain consists of  a catalytic subunit (Mr = 80 
kDa)  which is distinct for each calpain, and a smaller 
(M r = 30 kDa)  subunit which is common to both 
calpains 17. The different calpain subunits are the prod- 
ucts of  distinct genes in man 2°. Many proteins have been 
identified as potential calpain substrates by in vitro as- 
says 9. 
Both calpain 110'13 and calpain I111'12'26 have been iso- 
lated from peripheral  nerve. In vitro, each of these en- 
zymes is capable of degrading neurofilaments 1°-13'26 in 
addition to tubulin and microtubule associated proteins 
I and 115. Calpain II  in the central nervous system co- 
isolates with myelin, and is capable of  degrading several 
myelin proteins in vitro 4. The natural substrates of  
calpain in vivo must be determined by the spatial distri- 
bution of the enzyme and its function, dependent  on the 
local control of Ca 2÷ concentration. 
Previous immunocytochemical  studies of calpain dis- 
tribution in the nervous system have focused on the 
brain. Calpain I is found in neuronal perikarya in many  
brain regions 7'8'21'22'29 and has been described in glia by 
some 21'22, but not by other 7'8 investigators. Similarly, 
calpain II  has been described as predominantly in glia in 
brain by some 8, but not by other 7 investigators. In the 
only previous electron microscopic immunocytochemical  
study of peripheral nerve, an antibody directed against 
calpains showed immunoreactivi ty in monkey  nerve ex- 
tracellularly along collagen fibrils and basal lamina, along 
the axolemma,  and on neurofilaments intracellularly 1. In 
order to bet ter  understand the potential  role of calpain 
II  in normal  nerve function, we used a polyclonal anti- 
body specific for calpain I124 for light and electron mi- 
croscopic immunocytochemistry of rat sciatic nerve. 
The polyclonal antibody generated against rat platelet 
calpain II  (a generous gift of J. Elce) has been previously 
characterized 24. It has a much higher affinity for rat 
calpain II  than it does for rat calpain I (Fig. 2 in ref. 24). 
Fig. 1. Western blot of homogenate of sciatic nerve using the anti- 
calpain II antibody. The blot was exposed to the primary antibody 
(1:100) overnight, and the secondary antibody (1:200) for 1 h. A 
single band of M r = 80 kDa is seen (left lane). Molecular weight 
standards (right lane): 200, 98, 67 kDa (arrows). 
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In order to determine the antibody's specificity against 
proteins isolated from nerve, we performed a Western 
blot 14'31 of protein from rat sciatic nerve homogenized 
in 5 mM NaCl, 50 mM riffs, pH 7.4. The antibody rec- 
ognized a single band of M r = 80 kDa (Fig. 1), corre- 
sponding to the catalytic subunit of calpain II, and indi- 
cating that the antibody does not cross-react with other 
proteins (of different molecular weight) in peripheral 
nerve. 
For light microscopic immunocytochemistry, the rats 
were perfused with 4% paraformaldehyde for 1 h. The 
nerves were removed, cryoprotected with 2.3 M sucrose 
overnight, and 1 #m sections cut at -80 °C were placed on 
gelatin-coated slides. The slides were blocked with 1% 
ovalbumin in 20 mM glycine and 20 mM Tris-saline (pH 
7.6) for 15 min, exposed to the primary antibody (1:5 to 
1:100) overnight, followed by goat anti-rabbit antibody 
conjugated to biotin for 1 h, streptavidin peroxidase 
(1:100) for 1 h, and developed with diaminobenzidine 
tetrahydroehloride for 15 rain. 
For electron microscopy, ultrathin sections were cut at 
-120 °C, and the sections on grids exposed to the anti- 
serum (1:5 to 1:20 dilutions) for 2 h, followed by goat 
anti-rabbit IgG bound to 15 nm colloidal gold as de- 
scribed 15. The grids were stained for 20 rain with uranyl 
acetate and examined in a JEOL 100S electron micro- 
scope. As a control for the immunocytochemical reac- 
tions, we performed the same reaction but deleted the 
primary antibody. 
With both the light and the EM immunocytochemis- 
try, the amount of immunoreactivity decreased with pro- 
gressive dilution of the antibody, but the distribution of 
immunoreactivity was unchanged. 
This antigen-antibody reaction was very sensitive to 
aldehyde fixation. Post-embedding immunocytochemis- 
try on tissue embedded in LR White, or on etched, os- 
micated polybed or LR White grids produced no signal. 
Because of the low fixative content required to preserve 
antigenicity, the morphology in the cryo-ultrathin section 
was not optimal, and while the antigen could be local- 
ized at the cellular level, fine detail, particularly of the 
basal lamina and intracellular compartments, was not 
preserved. 
By light microscopy it was apparent that immunore- 
activity with this antibody was confined predominantly to 
Schwann cells (Fig. 2). Little immunoreactivity was de- 
tected within axons and there was no immunoreactivity 
in the myelin. The control showed no reaction product 
(Fig. 3). 
By electron microscopy, gold grains indicating immu- 
noreactivity were found diffusely within the cytoplasm of 
Schwann cells (Fig. 4), and were especially prominent 
along the plasmalemma of those cells (Fig. 4C). In many 
instances the plasmalemmal immunoreactivity was so 
Fig. 2. Light microscopic immunocytochemistry of sciatic nerve, 
stained with streptavidin-biotin-HRP. Immunoreactivity is seen in 
Schwann cell cytoplasm (arrows). A: cross section. Insert shows 
individual fibers separated from the endoneurial matrix. B: longi- 
tudinal section. Bars = 10/~m. Fig. 3. Control, with deletion of primary antibody. Bar = 10/~m. 
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Fig. 4. Electron microscopic immunocytochemistry, with eoUoidal 
gold, of eryo-ultrathin section of nerve, shows immunoreactivity 
along the Sehwann cell membrane (arrowheads), in Sehwann cell 
cytoplasm (stars), and in axoplasm (asterisks). Original magnifica- 
tions: A, ×16,800; B, ×22,400; C, ×25,500. 
dense that the gold particles obscured the extracellular 
face of the plasma membrane as well as the basal lam- 
ina (Fig. 4A, B). There was also clear immunoreactivity 
within axons (Fig. 4), but it appeared to be less intense 
than the immunoreactivity within Schwann cells. Al- 
though occasional gold particles were seen in myelin, 
there was no consistent immunoreactivity above back- 
ground in the myelin. Considered with the absence of 
myelin immunoreactivity by light microscopy, we feel it 
is most likely that calpain II is not found in significant 
amounts in compact myelin. 
These results are important in considering the possi- 
ble role of calpain II in the peripheral nerve. Calpain II 
has been implicated in the degradation of neurofilaments 
that characterizes Wallerian degeneration triggered by 
the influx of Ca 2÷ into axons, distal to the site of in- 
jury 27'32. The intra-axonal localization of calpain II  is 
consistent with this function. Similarly, calpain II can 
degrade myelin basic protein and myelin proteolipid pro- 
tein in vitro 4, and is capable of converting myelin asso- 
ciated glycoprotein to a smaller derivative 25. The 
Schwann cell localization suggests that this mechanism 
could potentially occur in vivo if local Ca 2+ concentra- 
tion were elevated, although the absence of myelin im- 
munoreactivity implies that it is not the mechanism for 
turnover of these proteins within myelin. 
The prominent association of calpain II with Schwann 
cell membranes was of particular interest. In other sys- 
tems, calpains associate with membrane phospholipids 16 
and with integral membrane proteins 23, and it has been 
suggested that calpain may be activated at the membrane 
and might mediate membrane lipid and protein interac- 
tions 9. 
The results of the current study differ from the results 
of Badalamente et al.1, who reported a predominantly 
extracellular localization of immunoreactivity in monkey 
peripheral nerve, using an anti-calpain antibody of un- 
defined isoenzyme specificity. However, our results are 
in agreement with the results reported by Hamakubo et 
al. 8, who found a glial localization of calpain II in brain, 
and detected immonostaining of axons as well, and are 
supported by the recent report of calpain II in Schwann 
cells in vitro 3. 
Recent experimental evidence suggests that calpain 
activity might be important in regulating neurite out- 
growth in vitro 28 and in vivo 2. Further studies of calpain 
distribution in response to nerve injury are currently un- 
derway in our laboratory. 
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